200184-60-7

Basic information

• Product Name: Methyl (S) - 4 - Methylene - 1 - (benzyloxycarbonyl)pyrrolidine carboxylate
• Synonyms: Methyl (S) - 4 - Methylene - 1 - (benzyloxycarbonyl)pyrrolidine carboxylate;(S)-1-Benzyloxycarbonyl-4-methylideneproline methyl ester;1-benzyl 2-methyl (2S)-4-methylidenepyrrolidine-1,2-dicarboxylate;1,2-Pyrrolidinedicarboxylic acid, 4-methylene-, 2-methyl 1-(phenylmethyl) ester, (2S)-
• CAS NO: 200184-60-7
• Molecular Formula: C₁₅H₁₇NO₄
• Molecular Weight: 275.29978
• Mol File: 200184-60-7.mol

Chemical Properties

• Boiling Point: 386.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.20±0.1 g/cm3(Predicted)
• PKA: -3.61±0.40(Predicted)
• CAS DataBase Reference: Methyl (S) - 4 - Methylene - 1 - (benzyloxycarbonyl)pyrrolidine carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl (S) - 4 - Methylene - 1 - (benzyloxycarbonyl)pyrrolidine carboxylate(200184-60-7)
• EPA Substance Registry System: Methyl (S) - 4 - Methylene - 1 - (benzyloxycarbonyl)pyrrolidine carboxylate(200184-60-7)

Safety Data

• Hazardous Substances Data: 200184-60-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
Methyl (S) 4 Methylene 1 (benzyloxycarbonyl)pyrrolidine carboxylate is used as a key building block for the synthesis of various pharmaceuticals and bioactive compounds. Its unique structure allows for the creation of complex molecules with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, Methyl (S) 4 Methylene 1 (benzyloxycarbonyl)pyrrolidine carboxylate is used as a reagent in chemical reactions. Its ability to form esters and participate in various organic transformations makes it a valuable component in the synthesis of a wide range of organic compounds.
Used in Material Development:
Methyl (S) 4 Methylene 1 (benzyloxycarbonyl)pyrrolidine carboxylate is also utilized in the development of new materials. Its chemical properties and reactivity contribute to the creation of innovative materials with potential applications in various industries.
Used in Chemical Reactions:
As a reagent in chemical reactions, Methyl (S) 4 Methylene 1 (benzyloxycarbonyl)pyrrolidine carboxylate is employed to facilitate specific transformations and reactions. Its versatility in participating in various chemical processes makes it an essential tool in the synthesis of complex organic molecules.

Upstream product

• 144539-45-7 4-methylene-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 
• 501-53-1 benzyl chloroformate 
• 75-11-6 diiodomethane 
• 2370-38-9 4-methylene-pyrrolidine-2-carboxylic acid 
• 84348-41-4 (S)-methyl 4-methylenepyrrolidine-2-carboxylate hydrochloride 
• 16217-15-5 1-benzyloxycarbonyl-4-oxo-L-proline methyl ester 
• 74-95-3 1,1-dibromomethane 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 67-56-1 methanol 
• 84348-38-9 (S)-1-(tert-butoxycarbonyl)-4-methylenepyrrolidine-2-carboxylic acid 

Downstream Products

• 942231-03-0 (2S,4R)-1-benzyl 2-methyl 4-hydroxy-4-(hydroxymethyl)pyrrolidine-1,2-dicarboxylate 
• 1256388-47-2 (S)-5-((benzyloxy)carbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid 
• 1256388-46-1 (S)-N-benzyloxycarbonyl-5-azaspiro[2.4]heptane-6-carboxylic acid methyl ester 
• 1352390-10-3 C₁₅H₁₉NO₆ 
• 443685-85-6 C₁₅H₂₁NO₅S 
• 443984-01-8 (2S)-1-benzyloxycarbonyl-2-cyanomethyl-4-methylpyrrolidine 
• 443983-99-1 (2S)-1-Benzyloxycarbonyl-2-hydroxymethyl-4-methylpyrrolidine 
• 443984-00-7 (2S)-1-benzyloxycarbonyl-4-methylproline methyl ester 
• 443685-77-6 (2S)-4-Methylproline Methyl Ester 

Relevant articles and documents

Compound as apoptosis protein inhibitor, and application thereof

The present invention belongs to the field of medical chemistry, relates to a class of compounds of apoptosis protein inhibitors, and applications thereof, and particularly provides a compound represented by a formula I, or an isomer thereof, a pharmaceut

Stereoselective synthesis of substituted pyrrolidines

The present invention relates to a halo-lactonization process for the stereoselective preparation of protected 1-(halo-methyl)-3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane derivatives of formula (II) wherein Hal and R1 are as defined in the description. The invention further relates to the novel compounds of formula (II), and to their further transformation to the compounds of formula (III) wherein R1, R2, R3, and R4 are as defined in the description.

METHODS FOR TREATING HCV

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

METHODS FOR TREATING HCV

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY

Described herein are N-hydroxyamlde antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical compositions compound of Formula (I): or a salt, solvate ti hydrate thereof, wherein A is (a) eachindicates a point of attachment.

BICYCLIC UNSATURATED TERTIARY AMINE COMPOUND

The present invention provides a bicyclic unsaturated tertiary amine compound capable of inhibiting the production of inflammatory cytokines.A compound of the following formula (1): (wherein, A represents pyrrole or pyrazole, R1 represents an aryl group or a heteroaryl group which may be substituted, R2 represents a heteroaryl group which may be substituted, and R3 represents an indolizine group), or a pharmacologically acceptable salt thereof, a pharmacologically acceptable ester thereof or other pharmacologically acceptable derivative thereof.

Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses

Compounds having activity against production of an inflammatory cytokine of formula (I)′: 1A′ is pyrrole; R1′ is phenyl or naphthyl; R2′ is pyridyl or pyrimidinyl; R3′ is (IIa)′, (IIb)′ or (IIc)′: 2m′ is 1; E′ is nitrogen; D′ is >C(R5′)—, R5′ is hydrogen, Substituent α′ or Substituent β′; B′ is nitrogen-containing 5-membered heterocyclic; R4′ is 1 to 3 substituents from Substituent α′, Substituent β′ and Substituent γ′; R1′ and R3′ are bonded to two atoms of the pyrrole adjacent to the pyrrole atom bonded to R2′; Substituent α′ is hydroxyl, nitro, cyano, halogen, alkoxy, halogeno alkoxy, alkylthio, halogeno alkylthio or —NRa′Rb′; Ra′ and Rb′ are hydrogen, alkyl, alkenyl, alkynyl, aralkyl or alkylsulfonyl, or Ra′ and Rb′ with the nitrogen atom form a heterocyclyl; Substituent β′ is alkyl, alkenyl, alkynyl, aralkyl or cycloalkyl; Substituent γ′ is oxo, hydroxyimino, alkoxyimino, alkylene, alkylenedioxy, alkylsulfinyl, alkylsulfonyl, aryl, aryloxy, alkylidenyl or aralkylidenyl.

COMPOUNDS SUBSTITUTED WITH BICYCLIC AMINO GROUPS

[Object]The object of the present invention is to provide compounds which are able to inhibit the production of inflammatory cytokines.[Solution]Compounds of the general formula (I) below, or pharmacologically acceptable salts, esters or other derivatives

Aromatic amidine derivatives useful as selective thrombin inhibitors

The present invention relates to a novel thrombin inhibitor which is effective even when orally administered. More specifically, the present invention relates to an aromatic amidine derivative represented by formula (I) and the salts thereof, which show potent selective inhibitory activity for thrombin in which (a), R, R1, R2, R3, A, W, Y and n are defined as described in the specification.